Eagle Pharmaceuticals Inc., of Woodcliff Lake, N.J., released positive results from a recently conducted clinical trial of its bendamustine hydrochloride product, in which the dose was delivered in a 50 mL admixture in 10 minutes vs. a 500 mL admixture in the 60-minute infusion required for Treanda (bendamustine; Cephalon Inc.).